Hepatoblastoma is a rare liver cancer in young children. AFP helps diagnose, guide treatment, and detect recurrence.
HEPATOBLASTOMA
RARE LIVER CANCER IN CHILDREN
WHAT IS HEPATOBLASTOMA
Hepatoblastoma is a rare liver cancer found mainly in children under three. It accounts for about 1% of childhood cancers. Early detection is key.
SYMPTOMS TO WATCH
Common signs include swelling in the belly, loss of appetite, weight loss, fatigue, and raised liver markers like AFP.
ROLE OF TUMOR MARKERS
Tumor markers are molecules made by cancer or the body in response. AFP is the main marker for hepatoblastoma, guiding diagnosis and treatment monitoring.
ALPHA-FETOPROTEIN AFP
AFP is a liver protein. High levels in children may indicate hepatoblastoma. Tracking AFP shows how treatments work and detects recurrence early.
AFP tests are done before surgery, after surgery, during chemotherapy, and for follow-ups. Regular checks guide doctors in adjusting treatment.
OTHER TUMOR MARKERS
Researchers also study β-hCG, DCP, and GPC3. These may help when AFP is low or to track tumor aggression.
DIAGNOSIS BEYOND MARKERS
Accurate diagnosis uses imaging (ultrasound, CT, MRI), biopsy, and genetic testing. Tumor markers alone are not enough.
SUPPORT FOR FAMILIES
Families should understand AFP testing, emotional support, and follow-ups. Access resources, counseling, and support groups to cope with hepatoblastoma.
Stories
More
CAN CORTISONE SHOTS TRIGGER SLEEPLESSNESS? 7 FACTS TO KNOW
7 KEY WAYS TO SUPPORT CHILDREN UNDERGOING CHEMOTHERAPY